FGF21 and Hepatic fibrosis: In the MCD diet-fed animal model of liver fibrosis, metformin or fibroblast growth factor-21 treatment attenuated liver fibrosis by inhibiting succinate and GPR91 signaling, further suggesting the succinate-GPR91 complex as a therapeutic target of liver fibrosis (43, 44).